SCHEMBL422550

SCHEMBL422550

OC(=S)CCCCCCCCCCCCBr

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.33
▸ LMNA P02545 1/20 0.32
▸ NFKB1 P19838 1/20 0.32
▸ PMP22 Q01453 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28118000 1.00 — —
SCHEMBL9336269 1.00 TSHR (0.33) TSHRLMNANFKB1PMP22
SCHEMBL20588841 0.88 — —
SCHEMBL17259074 0.84 TSHR (0.41) TSHRLMNANFKB1PMP22
SCHEMBL7712167 0.84 TSHR (0.41) TSHRLMNANFKB1PMP22
SCHEMBL7712357 0.84 TSHR (0.41) TSHRLMNANFKB1PMP22
SCHEMBL2786441 0.84 TSHR (0.41) TSHRLMNANFKB1PMP22
SCHEMBL2336676 0.84 TSHR (0.41) TSHRLMNANFKB1PMP22
SCHEMBL2026151 0.80 LMNA (0.38) TSHRLMNANFKB1PMP22
SCHEMBL23297342 0.74 TSHR (0.32) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240158421-A1 NITRIC OXIDE-RELEASING PARTICLES FOR NITRIC OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2024-05-16 — — US disclosed
US-11691995-B2 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2023-07-04 — — US disclosed
EP-3556401-A1 NITRIC OXIDE-RELEASING PARTICLES FOR NITRIC OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS The University of North Carolina at Chapel Hill (US) 2019-10-23 — — EP disclosed
EP-2669269-B1 NITRIC OXIDE-RELEASING PARTICLES FOR NITRIC OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS UNIV NORTH CAROLINA CHAPEL HILL (US) 2019-05-22 — — EP disclosed
US-9403851-B2 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2016-08-02 — — US disclosed
US-9403852-B2 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2016-08-02 — — US disclosed
US-20160060279-A1 NITRIC OXIDE-RELEASING PARTICLES FOR NITRIC OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2016-03-03 — — US disclosed
US-20150182543-A1 NITRIC OXIDE-RELEASING PARTICLES FOR NITRIC OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2015-07-02 — — US disclosed
US-8962029-B2 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2015-02-24 — — US disclosed
US-8956658-B2 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2015-02-17 — — US disclosed
US-20140058124-A1 NITRIC OXIDE-RELEASING PARTICLES FOR NITRIC OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2014-02-27 — — US disclosed
US-20140005426-A1 NITRIC OXIDE-RELEASING PARTICLES FOR NITRIC OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2014-01-02 — — US disclosed
EP-2669269-A2 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications The University of North Carolina At Chapel Hill (US) 2013-12-04 — — EP disclosed
US-8282967-B2 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2012-10-09 — — US disclosed
US-20120034169-A1 NITRIC OXIDE-RELEASING PARTICLES FOR NITRIC OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2012-02-09 — — US disclosed
US-20120021055-A1 NITRIC OXIDE-RELEASING PARTICLES FOR NITRIC OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2012-01-26 — — US disclosed
US-20090214618-A1 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 2009-08-27 — — US disclosed
EP-1888510-A2 NITRIC OXIDE-RELEASING PARTICLES FOR NITRIC OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS The University of North Carolina at Chapel Hill (US) 2008-02-20 — — EP disclosed
WO-2006128121-A2 NITRIC OXIDE-RELEASING PARTICLES FOR NITRIC OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) 2006-11-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691995-B2 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications NOS2, NOS3, NOS1 TSHR 673/4885LMNA 2261/4885NFKB1 1016/4885
US-20090214618-A1 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications NOS2, NOS3, NOS1 TSHR 673/4885LMNA 2261/4885NFKB1 1016/4885
US-20240158421-A1 NITRIC OXIDE-RELEASING PARTICLES FOR NITRIC OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS NOS2, NOS3, NOS1 TSHR 673/4885LMNA 2261/4885NFKB1 1016/4885
US-20120034169-A1 NITRIC OXIDE-RELEASING PARTICLES FOR NITRIC OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS NOS2, NOS3, NOS1 TSHR 673/4885LMNA 2261/4885NFKB1 1016/4885
US-20120021055-A1 NITRIC OXIDE-RELEASING PARTICLES FOR NITRIC OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS NOS2, NOS3, NOS1 TSHR 673/4885LMNA 2261/4885NFKB1 1016/4885
US-20140058124-A1 NITRIC OXIDE-RELEASING PARTICLES FOR NITRIC OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS NOS2, NOS3, NOS1 TSHR 673/4885LMNA 2261/4885NFKB1 1016/4885
US-20150182543-A1 NITRIC OXIDE-RELEASING PARTICLES FOR NITRIC OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS NOS2, NOS3, NOS1 TSHR 673/4885LMNA 2261/4885NFKB1 1016/4885
US-20160060279-A1 NITRIC OXIDE-RELEASING PARTICLES FOR NITRIC OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS NOS2, NOS3, NOS1 TSHR 673/4885LMNA 2261/4885NFKB1 1016/4885
US-20140005426-A1 NITRIC OXIDE-RELEASING PARTICLES FOR NITRIC OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS NOS2, NOS3, NOS1 TSHR 673/4885LMNA 2261/4885NFKB1 1016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback